Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

Share Price is delayed by 15 minutes
Get Live Data
2.65    0.15 (5.77%)
Bid:
2.55
Ask:
2.75
Spread: 0.20 (7.843%)
Market Cap: £123.06m
AEX Live PriceLast checked at - London Stock Exchange

Intraday Aminex Share Chart

Holdings in Company

17 Aug 2010 10:30

RNS Number : 1837R
Aminex PLC
17 August 2010
 



 

 

 

STANDARD FORM TR-1 VOTING RIGHTS ATTACHED TO SHARES- ARTICLE 12(1) OF DIRECTIVE 2004/109/EC FINANCIAL INSTRUMENTS - ARTICLE 11(3) OF THE COMMISSION DIRECTIVE 2007/14/ECi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Aminex PLC

2. Reason for the notification (please tick the appropriate box or boxes):

[X] an acquisition or disposal of voting rights

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ] an event changing the breakdown of voting rights

[ ] other: change in Issue Share Capital.

3. Full name of person(s) subject to the notification obligationiii: JPMorgan Asset Management Holdings Inc.

4. Full name of shareholder(s) (if different from 3.)iv: JPMorgan Asset Management (UK) Limited

5. Date of the transaction and date on which the threshold is crossed or reachedv:

13 August 2010

6. Date on which issuer notified: 16 August 2010

7. Threshold(s) that is/are crossed or reached: 5%, 4%

8. Notified details:

 

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

 

Direct

 

Indirect

 

Direct

 

Indirect

IE0003073255

23,643,899

23,643,899

16,693,899

0

16,693,899

0

3.88%

 

SUBTOTAL A (based on aggregate voting rights)

 

16,693,899

 

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Nil

SUBTOTAL B (in relation to all expiration dates)

 

Nil

 

Total (A+B)

 

16,693,899

number of voting rights

 

16,693,899

% of voting rights

 

3.88%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicablexvii:

 

Total disclosable holding for JPMorgan Asset Management Holdings Inc: 16,693,899 (3.88%)

 

Holdings by controlled undertakings of JPMorgan Asset Management Holdings Inc.. are as follows:

 

JPMorgan Asset Management (UK) Limited: 16,693,899 (3.88%)

 

 

10. In case of proxy voting: [name of the proxy holder] will cease to hold [number] voting rights as of [date]. N/A

11. Additional information: N/A

Done at [place] on [date].

 

ANNEX TO THE STANDARD FORM TR-1 xviii

a) Identity of the person or legal entity subject to the notification obligation:

Full name (including legal form for legal entities)

JPMorgan Asset Management Holdings Inc.

Contact address (registered office for legal entities)

270 Park Avenue, New York, NY10017

Phone number

001 212 270 6000

Other useful information (at least legal representative for legal persons)

N/A

 

b) Identity of the notifier, if applicablexix:

Full name

Richard Lock

Contact address

JPmorgan Chase, 13th Floor, 125 London Wall, London, EC2Y 5AJ

Phone number

0207 7777 0423

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) N/A

 

c) Additional information

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAPPXFSPEEEF
Date   Source Headline
1st Jun 20269:49 amRNSTotal Voting Rights
11th May 20264:07 pmRNSDirector/PDMR Shareholding
11th May 20264:02 pmRNSExercise of Options and Total Voting Rights
30th Apr 20265:29 pmRNSDirector/PDMR Shareholding
28th Apr 20269:11 amRNSFinal Results and Annual Report 2025
12th Mar 20264:43 pmRNSHolding in Company
12th Mar 20264:40 pmRNSPerson Closely Associated Dealing
27th Feb 202612:11 pmRNSExercise of Options and Total Voting Rights
3rd Feb 20261:45 pmRNSNtorya Operations Update
23rd Jan 20267:00 amRNSNtorya to Madimba Pipeline
18th Dec 20257:00 amRNSNtorya Operations Update
31st Oct 20257:00 amRNSTotal Voting Rights
6th Oct 20257:00 amRNSStrategic Placing to fund Aminex to Ntorya Revenue
26th Sep 20257:00 amRNS2025 Half-Yearly Financial Report
27th Aug 20257:00 amRNSNtorya Operations Update
24th Jul 20254:03 pmRNSResult of AGM
17th Jul 202512:00 pmRNSNtorya Operations Update
3rd Jul 20253:15 pmRNSNtorya to Madimba Pipeline Contract Awarded
30th Jun 202511:31 amRNSNotice of AGM
30th Apr 20254:21 pmRNS2024 Annual Report and Accounts
29th Apr 20254:53 pmRNSFinal Results and Annual Report 2024
5th Mar 20257:00 amRNSNtorya Operations Update
30th Sep 20247:00 amRNS2024 Half-Yearly Financial Report
11th Sep 20242:27 pmRNSNtorya Development Licence handover ceremony
27th Jun 202412:55 pmRNSResult of AGM
19th Jun 20243:02 pmRNSDirector/PDMR Dealing
19th Jun 20242:31 pmRNSExercise of Options and Total Voting Rights
3rd Jun 20247:00 amRNSNotice of AGM
23rd May 20244:04 pmRNSNtorya Development Licence Granted
10th May 20247:00 amRNSUpdate on Ntorya to Madimba Pipeline
29th Apr 20247:01 amRNSFinal Results and Annual Report 2023
29th Apr 20247:00 amRNSFunding Facility agreed with Eclipse Investments
29th Feb 20247:00 amRNSRuvuma Seismic Update
10th Jan 20242:49 pmRNSRuvuma Gas Sales Agreement signed
31st Oct 20235:00 pmRNSKiliwani Operations Update
29th Sep 20237:00 amRNS2023 Half-Yearly Financial Report
1st Sep 20237:00 amRNSDirectorate Change
13th Jul 20234:26 pmRNSResult of AGM
12th Jul 20237:00 amRNSRuvuma Operations Update
20th Jun 20237:00 amRNSNotice of AGM
2nd Jun 20233:13 pmRNSDirector/PDMR Shareholding
26th May 20237:00 amRNSPublication of New Research
28th Apr 20236:13 pmRNSFinal Results and Annual Report 2022
2nd Mar 20237:00 amRNSStrategy/Company/Ops Update
6th Feb 202311:05 amRNSSecond Price Monitoring Extn
6th Feb 202311:00 amRNSPrice Monitoring Extension
6th Feb 20239:05 amRNSSecond Price Monitoring Extn
6th Feb 20239:00 amRNSPrice Monitoring Extension
28th Nov 202211:05 amRNSSecond Price Monitoring Extn
28th Nov 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.